TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | -23 | -29 | 29 | 6 | 16 | -0 |
| P | %wins | 100 | 0 | 0 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/23/18 15:03 | 3/21/18 | CASI | Casi Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Idg-Accel China Growth Fund III L.P. | T | P.d | 9,846 | 3.19 | 0 | 3,086 | 46 | 9,773 | M | ||||||||||||||||
1/27/16 21:23 | 3/7/13 | CASI | Casi Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Idg-Accel China Growth Fund III L.P. | T | P.d | 2,500 | 2.40 | 0 | 1,042 | 24 | 5,452 | M | -46 | -37 | -35 | -21 | 3 | 10 | 32 | 45 | 0 | -23 | -29 | 29 | 6 | 16 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |